Advertisement
Review| Volume 81, ISSUE 3, P357-371, September 2020

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

      Highlights

      • SARS-CoV-2 viral loads peak from upper respiratory tract samples around symptom onset.
      • Viral loads from sputum samples may be higher than upper respiratory tract samples.
      • Viral loads appear to be similar between asymptomatic and symptomatic patients.
      • The prolonged virus detection in stool samples has unclear clinical significance.
      • Patients may not be infectious for the entire duration of virus detection.

      Summary

      Objectives

      To summarise the evidence on the detection pattern and viral load of SARS-CoV-2 over the course of an infection (including any asymptomatic or pre-symptomatic phase), and the duration of infectivity.

      Methods

      A systematic literature search was undertaken in PubMed, Europe PubMed Central and EMBASE from 30 December 2019 to 12 May 2020.

      Results

      We identified 113 studies conducted in 17 countries. The evidence from upper respiratory tract samples suggests that the viral load of SARS-CoV-2 peaks around symptom onset or a few days thereafter, and becomes undetectable about two weeks after symptom onset; however, viral loads from sputum samples may be higher, peak later and persist for longer. There is evidence of prolonged virus detection in stool samples, with unclear clinical significance.
      No study was found that definitively measured the duration of infectivity; however, patients may not be infectious for the entire duration of virus detection, as the presence of viral ribonucleic acid may not represent transmissible live virus.

      Conclusion

      There is a relatively consistent trajectory of SARS-CoV-2 viral load over the course of COVID-19 from respiratory tract samples, however the duration of infectivity remains uncertain.

      Keywords

      Introduction

      The Coronavirus Disease 2019 (COVID-19) pandemic is a public health emergency of international concern causing a substantial number of cases and deaths globally.
      • Dong E.
      • Du H.
      • Gardner L
      An interactive web-based dashboard to track COVID-19 in real time.
      ,
      • Sohrabi C.
      • Alsafi Z.
      • O'Neill N.
      • Khan M.
      • Kerwan A.
      • Al-Jabir A.
      • et al.
      World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19).
      COVID-19 presents an unprecedented challenge to governments worldwide due to the transmissibility of the virus, the scale of its impact on morbidity and mortality, the uncertainty regarding the development of long-term immunity in those infected, the current lack of vaccine or treatment options, and the impact on healthcare systems, economies and society.
      • Fauci A.S.
      • Lane H.C.
      • Redfield R.R
      Covid-19 — Navigating the Uncharted.
      ,
      • Spinelli A.
      • Pellino G
      COVID-19 pandemic: perspectives on an unfolding crisis.
      Much remains unknown about COVID-19; however, evidence is emerging at a fast pace.
      • Lorenc T.
      • Khouja C.
      • Raine G.
      • Sutcliffe K.
      • Wright K.
      • Sowden A.
      • et al.
      COVID-19: living map of the evidence.
      Our team at the Health Information and Quality Authority (HIQA) of Ireland has conducted a series of rapid reviews on various public health topics relating to COVID-19. The rapid reviews arose directly from questions posed by policy makers and expert clinicians supporting the Irish National Public Health Emergency Team (NPHET). Hence, the findings of these reviews have informed the national response to the COVID-19 pandemic in Ireland,

      HIQA publishes COVID-19 evidence summaries to support work of the National Public Health Emergency Team [press release]. https://www.hiqa.ie/hiqa-news-updates/hiqa-publishes-covid-19-evidence-summaries-support-work-national-public-health: HIQA, 1 April 2020.

      and have implications for international health policy as well as clinical and public health guidance.
      Understanding the trajectory of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the duration of infectivity is of critical importance to controlling the pandemic.
      • Bedford J.
      • Enria D.
      • Giesecke J.
      • Heymann D.L.
      • Ihekweazu C.
      • Kobinger G.
      • et al.
      COVID-19: towards controlling of a pandemic.
      As SARS-CoV-2 is a novel virus in the human population, there is substantial uncertainty regarding virological levels (i.e. detection and viral load) in patients and how this relates to infectivity and disease severity. Information relating to SARS-CoV-2 detection and viral load at different time points of an infection, including in those without any symptoms, will aid with the clinical interpretation of real-time reverse transcriptase polymerase chain reaction (rRT-PCR) test results. Furthermore, information pertaining to the duration of infectivity will help inform public health protocols for quarantine, isolation and contact tracing.
      We defined detection as the presence (i.e. detectability) or absence (i.e. undetectability) of the virus in a sample at a given time. We defined viral load as the quantity (or titre) of virus in a volume of fluid at a given time. For this current article, we summarise the available evidence to address the following two research questions:

      Materials and methods

      We conducted rapid reviews for a broad range of public health topics related to COVID-19 following a standardised protocol,

      Health Information and Quality Authority. Protocol for evidence synthesis support - COVID-19. https://www.hiqa.ie/sites/default/files/2020-04/Protocol-for-evidence-synthesis-support_1-4-COVID-19.pdf: HIQA, 2020.

      in keeping with Cochrane rapid review methodology guidance.
      • Garritty C.
      • Gartlehner G.
      • Kamel C.
      • King V.J.
      • Nussbaumer-Streit B.
      • Stevens A.
      • et al.
      Interim guidance from the cochrane rapid reviews methods group.
      Initially, we conducted a systematic literature search of electronic databases (PubMed, EMBASE, Science Direct, Cochrane, National Health Service [NHS] Evidence, and Infectious Diseases Society of America search of infectious disease journals) and pre-print servers (medRxiv, bioRxiv and Health Research Board [HRB] Open) using COVID-19 search terms. The purpose of the initial broad search was to identify all COVID-19 scientific and medical literature to answer a range of research questions. Due to the proliferation of COVID-19 literature, the vast majority of which were not relevant to our research question, we employed a more specific search strategy from 27 March 2020 onwards. Hence, we conducted a systematic literature search of PubMed, Europe PubMed Central and EMBASE from 30 December 2019. The search combined terms for COVID-19 with terms for viral load, detection and infectivity. Only articles including human subjects were included. No language restrictions were applied. The last update for this rapid review was conducted on 12 May 2020. The protocol, which is available online, contains the detailed search strategies.

      Health Information and Quality Authority. Protocol for evidence synthesis support - COVID-19. https://www.hiqa.ie/sites/default/files/2020-04/Protocol-for-evidence-synthesis-support_1-4-COVID-19.pdf: HIQA, 2020.

      All potentially eligible papers, including non-peer-reviewed pre-prints, were exported to Endnote X8.2 and screened for relevance. Any study (regardless of design) that addressed the research question and met the inclusion criteria (Table 1) was included. For each included study, data on the study design, participant demographics and clinically relevant data were extracted. Various validated risk of bias tools were used for quality appraisal of included studies, where appropriate (e.g. Cochrane Risk of Bias (RoB) tool for Randomized Controlled Trials [RCTs]
      • Higgins J.P.T.
      • Altman D.G.
      • Gøtzsche P.C.
      • Jüni P.
      • Moher D.
      • Oxman A.D.
      • et al.
      The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
      and Risk Of Bias In Non-randomized studies of Interventions tool (ROBINS-I)).
      • Sterne J.A.
      • Hernán M.A.
      • Reeves B.C.
      • Savović J.
      • Berkman N.D.
      • Viswanathan M.
      • et al.
      ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
      For study designs where no universally accepted quality appraisal tool existed (e.g. case series, modelling studies), a de-novo tool, adapted from related tools, was used.

      Health Information and Quality Authority. Protocol for evidence synthesis support - COVID-19. https://www.hiqa.ie/sites/default/files/2020-04/Protocol-for-evidence-synthesis-support_1-4-COVID-19.pdf: HIQA, 2020.

      The findings of the research question were synthesised narratively due to the heterogeneity of study designs and data.
      Table 1Population, Outcomes and Study types (POS) framework for study inclusion.
      PopulationPatients (of any age) infected with COVID-19 with information on either viral load or detection during infection (including in the pre-symptomatic phase) and/or duration of infectivity.
      • Subgroups of interest adults vs children
      OutcomesPrimary outcomes:
      • Ribonucleic Acid (viral load or detection) during infection (the test used [including cut-off if reported], sample site [e.g. upper/lower respiratory, faecal, urine], test timing [number of days symptomatic pre-testing (if relevant)], clinical characteristics of the population (age, comorbidity) and clinical syndrome associated with COVID-19 (asymptomatic, mild illness, pneumonia, severe pneumonia, ARDS, sepsis, septic shock)
      • Duration of virus detection (define start as: first confirmed positive test (or symptom onset); use WHO criteria (where reported) for end of detection, that is, two consecutive negative PCR tests 24 h apart).
      • Period of infectiousness/infectivity (defined as the time interval during which SARS-CoV-2 may be transferred from an infected person to another person).
      Types of StudiesInclude:
      • any study that reports on the viral load or duration of viral detection or infectivity of COVID-19.
      Exclude:
      • studies where COVID-19 was not confirmed with a laboratory test.
      Key: ARDS - acute respiratory distress syndrome; COVID-19 - coronavirus disease 2019; SARS-CoV-2 - severe acute respiratory syndrome coronavirus 2; WHO - World Health Organization.

      Results

      Summary of included studies

      A total of 113 studies were included
      • An J.
      • Liao X.
      • Xiao T.
      • Qian S.
      • Yuan J.
      • Ye H.
      • et al.
      Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test.
      • Arons M.M.
      • Hatfield K.M.
      • Reddy S.C.
      • Kimball A.
      • James A.
      • Jacobs J.R.
      • et al.
      Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
      • Cai J.
      • Xu J.
      • Lin D.
      • z Yang
      • Xu L.
      • Qu Z.
      • et al.
      A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features.
      • Cai Q.
      • Huang D.
      • Ou P.
      • Yu H.
      • Zhu Z.
      • Xia Z.
      • et al.
      COVID-19 in a designated infectious diseases hospital outside Hubei Province,China.
      • Cao B.
      • Wang Y.
      • Wen D.
      • Liu W.
      • Wang J.
      • Fan G.
      • et al.
      A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19.
      • Chang Mo G
      • Yuan X.
      • Tao Y.
      • Peng X.
      • Wang F.
      • et al.
      Time kinetics of viral clearance and resolution of symptoms in novel coronavirus infection.
      • Chen D.
      • Xu W.
      • Lei Z.
      • Huang Z.
      • Liu J.
      • Gao Z.
      • et al.
      Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report.
      • Chen J.
      • Qi T.
      • Liu L.
      • Ling Y.
      • Qian Z.
      • Li T.
      • et al.
      Clinical progression of patients with COVID-19 in Shanghai, China.
      • Chen W.
      • Lan Y.
      • Yuan X.
      • Deng X.
      • Li Y.
      • Cai X.
      • et al.
      Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity.
      • Chen Y.
      • Chen L.
      • Deng Q.
      • Zhang G.
      • Wu K.
      • Ni L.
      • et al.
      The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
      • Cheng C.Y.
      • Lee Y.L.
      • Chen C.P.
      • Lin Y.C.
      • Liu C.E.
      • Liao C.H.
      • et al.
      Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
      • Cheng H.-.Y.
      • Jian S.-W.
      • Liu D.-P.
      • Ng T.-C.
      • Huang W.-T.
      • Lin H.-H
      Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset.
      • Cheng S.-.C.
      • Chang Y.-.C.
      • Fan Chiang Y.-.L.
      • Chien Y.-.C.
      • Cheng M.
      • Yang C.-.H.
      • et al.
      First case of Coronavirus disease 2019 (COVID-19) pneumonia in Taiwan.
      • Corman V.M.
      • Rabenau H.F.
      • Adams O.
      • Oberle D.
      • Funk M.B.
      • Keller-Stanislawski B.
      • et al.
      SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.
      • Fan Q.
      • Pan Y.
      • Wu Q.
      • Liu S.
      • Song X.
      • Xie Z.
      • et al.
      Anal swab findings in an infant with COVID-19.
      • Fang Z.
      • Zhang Y.
      • Hang C.
      • Zhang W.
      • Ai J.
      • Li S
      Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients.
      • Fu S.
      • Fu X.
      • Song Y.
      • Li M.
      • P-h Pan
      • Tang T.
      • et al.
      Virologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, China.
      • Gao J.
      • Liu J.Q.
      • Wen H.J.
      • Liu H.
      • Hu W.D.
      • Han X.
      • et al.
      The unsynchronized changes of CT image and nucleic acid detection in COVID-19: reports the two cases from Gansu, China.
      • Gautret P.
      • Lagier J.C.
      • Parola P.
      • Hoang V.T.
      • Meddeb L.
      • Mailhe M.
      • et al.
      Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
      • Goh K.J.
      • Choong M.C.
      • Cheong E.H.
      • Kalimuddin S.
      • Duu Wen S.
      • Phua G.C.
      • et al.
      Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID-19 infection.
      • He X.
      • Lau E.H.
      • Wu P.
      • Deng X.
      • Wang J.
      • Hao X.
      • et al.
      Temporal dynamics in viral shedding and transmissibility of COVID-19.
      • Hill D.K.J.
      • Russell D.C.D.
      • Clifford D.S.
      • Templeton D.K.
      • Mackintosh D.C.L.
      • Koch D.O.
      • et al.
      The index case of SARS-CoV-2 in Scotland: a case report.
      • Holshue M.L.
      • DeBolt C.
      • Lindquist S.
      • Lofy K.H.
      • Wiesman J.
      • Bruce H.
      • et al.
      First case of 2019 novel coronavirus in the United States.
      • Hu X.
      • Xing Y.
      • Jia J.
      • Ni W.
      • Liang J.
      • Zhao D.
      • et al.
      Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19.
      • Hu Z.
      • Song C.
      • Xu C.
      • Jin G.
      • Chen Y.
      • Xu X.
      • et al.
      Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.
      • Huang J.
      • Mao T.
      • Li S.
      • Wu L.
      • Xu X.
      • Li H.
      • et al.
      Long period dynamics of viral load and antibodies for SARS-CoV-2 infection: an observational cohort study.
      • Jahan Y.
      • Rahman S.
      • Rahman A
      COVID-19: a case report from Bangladesh perspective.
      • Jiang X.
      • Luo M.
      • Zou Z.
      • Wang X.
      • Chen C.
      • Qiu J
      Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days.
      • Jing Q.-.L.
      • Liu M.-.J.
      • Yuan J.
      • Zhang Z.-.B.
      • Zhang A.-R.
      • Dean N.
      • et al.
      Household secondary attack rate of COVID-19 and associated determinants.

      Jones T.C., Mühlemann B., Veith T., Zuchowski M., Hofmann J., Stein A., et al. An analysis of SARS-CoV-2 viral load by patient age. https://zoonosen.charite.de/fileadmin/user_upload/microsites/m_cc05/virologie-ccm/dateien_upload/Weitere_Dateien/analysis-of-SARS-CoV-2-viral-load-by-patient-age.pdf: 2020.

      • K-q Kam
      • CF Yung
      • Cui L.
      • Lin Tzer Pin R.
      • Mak T.M.
      • Maiwald M.
      • et al.
      A well infant with coronavirus disease 2019 (COVID-19) with high viral load.
      • Kim J.Y.
      • Ko J.H.
      • Kim Y.
      • Kim Y.J.
      • Kim J.M.
      • Chung Y.S.
      • et al.
      Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.
      • Kujawski S.A.
      • Wong K.K.
      • Collins J.P.
      • Epstein L.
      • Killerby M.E.
      • Midgley C.M.
      • et al.
      Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.
      • La Scola B.
      • Le Bideau M.
      • Andreani J.
      • Hoang V.T.
      • Grimaldier C.
      • Colson P.
      • et al.
      Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.
      • Lavezzo E.
      • Franchin E.
      • Ciavarella C.
      • Cuomo-Dannenburg G.
      • Barzon L.
      • Del Vecchio C.
      • et al.
      Suppression of COVID-19 outbreak in the municipality of Vo, Italy.
      • Le H.T.
      • Nguyen L.V.
      • Tran D.M.
      • Do H.T.
      • Tran H.T.
      • Le Y.T.
      • et al.
      The first infant case of COVID-19 acquired from a secondary transmission in Vietnam.
      • Le T.Q.M.
      • Takemura T.
      • Moi M.L.
      • Nabeshima T.
      • Nguyen L.K.H.
      • Hoang V.M.P.
      • et al.
      Severe acute respiratory syndrome coronavirus 2 shedding by travelers, Vietnam, 2020.
      • Lee N.-.Y.
      • Li C.-.W.
      • Tsai H.-.P.
      • Chen P.-.L.
      • Syue L.-S.
      • Li M.-.C.
      • et al.
      A case of COVID-19 and pneumonia returning from Macau in Taiwan: clinical course and anti-SARS-CoV-2 IgG dynamic.
      • Lescure F.-.X.
      • Bouadma L.
      • Nguyen D.
      • Parisey M.
      • Wicky P.-H.
      • Behillil S.
      • et al.
      Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
      • L'Huillier A.
      • Torriani G.
      • Pigny F.
      • Kaiser L.
      • Eckerle I
      Shedding of infectious SARS-CoV-2 in symptomatic neonates, children and adolescents.
      • Li N.
      • Wang X.
      • Lv T
      Prolonged SARS-CoV-2 RNA shedding: not a rare phenomenon.
      • Li Y.
      • Hu Y.
      • Yu Y.
      • Zhang X.
      • Li B.
      • Wu J.
      • et al.
      Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China.
      • Lillie P.J.
      • Samson A.
      • Li A.
      • Adams K.
      • Capstick R.
      • Barlow G.D.
      • et al.
      Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission.
      • Lim J.
      • Jeon S.
      • Shin H.Y.
      • Kim M.J.
      • Seong Y.M.
      • Lee W.J.
      • et al.
      Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR.
      • Ling Y.
      • Xu S.-.B.
      • Lin Y.-.X.
      • Tian D.
      • Zhu Z.-.Q.
      • Dai F.-.H.
      • et al.
      Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
      • Liu F.
      • Xu A.
      • Zhang Y.
      • Xuan W.
      • Yan T.
      • Pan K.
      • et al.
      Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression.
      • Liu W.D.
      • Chang S.Y.
      • Wang J.T.
      • Tsai M.J.
      • Hung C.C.
      • Hsu C.L.
      • et al.
      Prolonged virus shedding even after seroconversion in a patient with COVID-19.
      • Liu Y.
      • Yan L.-M.
      • Wan L.
      • Xiang T.-.X.
      • Le A.
      • Liu J.-.M.
      • et al.
      Viral dynamics in mild and severe cases of COVID-19.
      • Lo I.L.
      • Lio C.F.
      • Cheong H.H.
      • Lei C.I.
      • Cheong T.H.
      • Zhong X.
      • et al.
      Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau.
      • Lv D-f
      • Ying Q-m
      • Weng Y-s
      • Shen C-b
      • Chu J-g
      • Kong J-p
      • et al.
      Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus disease 2019 patient.
      • Ma X.
      • Su L.
      • Zhang Y.
      • Zhang X.
      • Gai Z.
      • Zhang Z
      Do children need a longer time to shed SARS-CoV-2 in stool than adults?.
      • Marchand-Senécal X.
      • Kozak R.
      • Mubareka S.
      • Salt N.
      • Gubbay J.B.
      • Eshaghi A.
      • et al.
      Diagnosis and management of first case of COVID-19 in Canada: lessons applied from SARS.
      • Meng J.
      • Xiao G.
      • Zhang J.
      • He X.
      • Ou M.
      • Bi J.
      • et al.
      Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.
      • Nicastri E.
      • D'Abramo A.
      • Faggioni G.
      • De Santis R.
      • Mariano A.
      • Lepore L.
      • et al.
      Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020.
      • Pan Y.
      • Zhang D.
      • Yang P.
      • Poon L.L.M.
      • Wang Q
      Viral load of SARS-CoV-2 in clinical samples.
      • Paoli D.
      • Pallotti F.
      • Colangelo S.
      • Basilico F.
      • Mazzuti L.
      • Turriziani O.
      • et al.
      Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab.
      • Peng Z.
      • Wang J.
      • Mo Y.
      • Duan W.
      • Xiang G.
      • Yi M.
      • et al.
      Unlikely SARS-CoV-2 vertical transmission from mother to child: a case report.
      • Pongpirul W.A.
      • Mott J.A.
      • Woodring J.V.
      • Uyeki T.M.
      • MacArthur J.R.
      • Vachiraphan A.
      • et al.
      Clinical characteristics of patients hospitalized with coronavirus disease, Thailand.
      • Qian G.Q.
      • Chen X.Q.
      • Lv D.F.
      • Ma A.H.Y.
      • Wang L.P.
      • Yang N.B.
      • et al.
      Duration of SARS-CoV-2 viral shedding during COVID-19 infection.
      • Qiu H.
      • Wu J.
      • Hong L.
      • Luo Y.
      • Song Q.
      • Chen D
      Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.
      • Qu Y.-.M.
      • Cong H.-.Y.
      Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19.
      • Saito M.
      • Adachi E.
      • Yamayoshi S.
      • Koga M.
      • Iwatsuki-Horimoto K.
      • Kawaoka Y.
      • et al.
      Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan.
      • Scott S.E.
      • Zabel K.
      • Collins J.
      • Hobbs K.C.
      • Kretschmer M.J.
      • Lach M.
      • et al.
      First Mildly Ill, non-hospitalized case of coronavirus disease 2019 (COVID-19) without viral transmission in the United States — Maricopa County, Arizona, 2020.
      • Segar S.
      • Bouland D.
      • Torriani F.
      • Kwak K.
      • Asudani D.
      • Taplitz R.
      • et al.
      Flight of the COVID-19 patient: experience with aWuhan evacuee- a case report.
      • Shen C.
      • Wang Z.
      • Zhao F.
      • Yang Y.
      • Li J.
      • Yuan J.
      • et al.
      Treatment of 5 critically ill patients with COVID-19 with convalescent plasma.
      • Shi F.
      • Wu T.
      • Zhu X.
      • Ge Y.
      • Zeng X.
      • Chi Y.
      • et al.
      Association of viral load with serum biomakers among COVID-19 cases.
      • Song R.
      • Han B.
      • Song M.
      • Wang L.
      • Conlon C.P.
      • Dong T.
      • et al.
      Clinical and epidemiological features of COVID-19 family clusters in Beijing, China.
      • Stebbing J.
      • Krishnan V.
      • Sd Bono
      • Ottaviani S.
      • Casalini G.
      • Richardson P.
      • et al.
      Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
      • Su L.
      • Ma X.
      • Yu H.
      • Zhang Z.
      • Bian P.
      • Han Y.
      • et al.
      The different clinical characteristics of corona virus disease cases between children and their families in China–the character of children with COVID-19.
      • Tan L.
      • Kang X.
      • Ji X.
      • Wang Q.
      • li Y.
      • Wang Q.
      • et al.
      Validation of predictors of disease severity and outcomes in COVID-19 patients: a descriptive and retrospective study.
      • Tan L.
      • Kang X.
      • Zhang B.
      • Zheng S.
      • Liu B.
      • Yu T.
      • et al.
      Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: the clinical features, laboratory tests, plasma therapy and implications for public health management.
      • Tan L.V.
      • Ngoc N.M.
      • That B.T.T.
      • Uyen L.T.T.
      • Hong N.T.T.
      • Dung N.T.P.
      • et al.
      Duration of viral detection in throat and rectum of a patient with COVID-19.
      • Tan X.
      • Huang J.
      • Zhao F.
      • Zhou Y.
      • Li J.Q.
      • Wang X.Y
      Clinical features of children with SARS-CoV-2 infection: an analysis of 13 cases from Changsha, China.
      • Tan Y.P.
      • Tan B.Y.
      • Pan J.
      • Wu J.
      • Zeng S.Z.
      • Wei H.Y
      Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China.
      • Thevarajan I.
      • Nguyen T.H.O.
      • Koutsakos M.
      • Druce J.
      • Caly L.
      • van de Sandt C.E.
      • et al.
      Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19.
      • To K.K.-.W.
      • Tsang O.T.-.Y.
      • Leung W.-.S.
      • Tam A.R.
      • Wu T.-.C.
      • Lung D.C.
      • et al.
      Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
      • To K.K.-.W.
      • Tsang O.T.-.Y.
      • Yip C.C.-.Y.
      • Chan K.-.H.
      • Wu T.-.C.
      • Chan J.M.-.C.
      • et al.
      Consistent detection of 2019 novel coronavirus in Saliva.
      • Tu Y.-.H.
      • Wei Y.-.Y.
      • Zhang D.-W.
      • Chen C.-S.
      • Hu X.-.W.
      • Fei G
      Analysis of factors affected the SARS-CoV-2 viral shedding time of COVID-19 patients in Anhui, China: a retrospective study.
      • Wan R.
      • Mao Z.Q.
      • He L.Y.
      • Hu Y.C.
      • Wei C
      Evidence from two cases of asymptomatic infection with SARS-CoV-2: are 14 days of isolation sufficient?.
      • Wang C.
      • Huang L.
      • Lu W.
      • Chen G.
      • Cai Y.
      • Li X.
      • et al.
      Clinical characteristics of pneumonia patients of long courses infected with SARS-CoV-2.
      • Wang J.-.C.
      • Song S.
      • Yuan B.
      • Liu H.-.Q.
      • Yang Z.-.R.
      • Chen Y.-.X.
      • et al.
      Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation.
      • Wang L.
      • Gao Y.H.
      • Lou L.L.
      • Zhang G.J
      The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China.
      • Wang Y.
      • Liu C.
      • Meng Q.
      • Gui S.
      • Wu Y.
      • Cheng P.
      • et al.
      A case report of moderate COVID-19 with an extremely long-term viral shedding period in China.
      • Wei W.
      • Li Z.
      • Chiew C.
      • Yong S.
      • Toh M.
      • Lee V
      Presymptomatic transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020.
      • Wei X.S.
      • Wang X.
      • Niu Y.R.
      • Ye L.L.
      • Peng W.B.
      • Wang Z.H.
      • et al.
      Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19.
      • Wei X.S.
      • Wang X.R.
      • Zhang J.C.
      • Yang W.B.
      • Ma W.L.
      • Yang B.H.
      • et al.
      A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2.
      • Woelfel R.
      • Corman V.M.
      • Guggemos W.
      • Seilmaier M.
      • Zange S.
      • Mueller M.A.
      • et al.
      Virological assessment of hospitalized patients With COVID-2019.
      • Wu Y.
      • Guo C.
      • Tang L.
      • Hong Z.
      • Zhou J.
      • Dong X.
      • et al.
      Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.
      • Xiao A.T.
      • Tong Y.X.
      • Gao C.
      • Zhu L.
      • Zhang Y.J.
      • Zhang S
      Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study.
      • Xing Y.
      • Mo P.
      • Xiao Y.
      • Zhao O.
      • Zhang Y.
      • Wang F
      Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020.
      • Xing Y.
      • Ni W.
      • Wu Q.
      • Li W.
      • Li G.
      • Tong J.
      • et al.
      Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019.
      • Xu K.
      • Chen Y.
      • Yuan J.
      • Yi P.
      • Ding C.
      • Wu W.
      • et al.
      Factors associated with prolonged viral RNA shedding in patients with COVID-19.
      • Xu T.
      • Chen C.
      • Zhu Z.
      • Cui M.
      • Chen C.
      • Dai H.
      • et al.
      Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19.
      • Xu T.
      • Huang R.
      • Zhu L.
      • Wang J.
      • Cheng J.
      • Zhang B.
      • et al.
      Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection.
      • Xu Y.
      • Li X.
      • Zhu B.
      • Liang H.
      • Fang C.
      • Gong Y.
      • et al.
      Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.
      • Yan D.
      • Liu X-y
      • Zhu Y-n
      • Huang L.
      • Dan B-t
      • Zhang G-j
      • et al.
      Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in patients with SARS-CoV-2 infection.
      • Yang J.R.
      • Deng D.T.
      • Wu N.
      • Yang B.
      • Li H.J.
      • Pan X.B
      Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.
      • Yang P.
      • Ding Y.
      • Xu Z.
      • Pu R.
      • Li P.
      • Yan J.
      • et al.
      Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China.
      • Yang R.
      • Gui X.
      • Xiong Y
      Patients with respiratory symptoms are at greater risk of COVID-19 transmission.
      • Yongchen Z.
      • Shen H.
      • Wang X.
      • Shi X.
      • Li Y.
      • Yan J.
      • et al.
      Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients.
      • Young B.E.
      • Ong S.W.X.
      • Kalimuddin S.
      • Low J.G.
      • Tan S.Y.
      • Loh J.
      • et al.
      Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore.
      • Yu F.
      • Yan L.
      • Wang N.
      • Yang S.
      • Wang L.
      • Tang Y.
      • et al.
      Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients.
      • Yu X.
      • Sun S.
      • Shi Y.
      • Wang H.
      • Zhao R.
      • Sheng J
      SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression.
      • Yuan J.
      • Kou S.
      • Liang Y.
      • Zeng J.
      • Pan Y.
      • Liu L
      Clinical characteristics on 25 discharged patients with COVID-19 virus returning.
      • Yuan Y.
      • Wang N.
      • Ou X
      Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly.
      • Zha L.
      • Li S.
      • Pan L.
      • Tefsen B.
      • Li Y.
      • French N.
      • et al.
      Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19).
      • Zhang N.
      • Gong Y.
      • Meng F.
      • Bi Y.
      • Yang P.
      • Wang F
      Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients.
      • Zhang T.
      • Cui X.
      • Zhao X.
      • Wang J.
      • Zheng J.
      • Zheng G.
      • et al.
      Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia.
      • Zheng S.
      • Fan J.
      • Yu F.
      • Feng B.
      • Lou B.
      • Zou Q.
      • et al.
      Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
      • Zhou B.
      • She J.
      • Wang Y.
      • Ma X
      The duration of viral shedding of discharged patients with severe COVID-19.
      • Zhou F.
      • Yu T.
      • Du R.
      • Fan G.
      • Liu Y.
      • Liu Z.
      • et al.
      Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
      • Zhu L.
      • Gong N.
      • Liu B.
      • Lu X.
      • Chen D.
      • Chen S.
      • et al.
      Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China.
      • Zou L.
      • Ruan F.
      • Huang M.
      • Liang L.
      • Huang H.
      • Hong Z.
      • et al.
      SARS-CoV-2 viral load in upper respiratory specimens of infected patients.
      (Table 2 and Appendix Table 1). Seventy-four studies were conducted in China.
      • An J.
      • Liao X.
      • Xiao T.
      • Qian S.
      • Yuan J.
      • Ye H.
      • et al.
      Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test.
      ,
      • Cai J.
      • Xu J.
      • Lin D.
      • z Yang
      • Xu L.
      • Qu Z.
      • et al.
      A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features.
      • Cai Q.
      • Huang D.
      • Ou P.
      • Yu H.
      • Zhu Z.
      • Xia Z.
      • et al.
      COVID-19 in a designated infectious diseases hospital outside Hubei Province,China.
      • Cao B.
      • Wang Y.
      • Wen D.
      • Liu W.
      • Wang J.
      • Fan G.
      • et al.
      A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19.
      • Chang Mo G
      • Yuan X.
      • Tao Y.
      • Peng X.
      • Wang F.
      • et al.
      Time kinetics of viral clearance and resolution of symptoms in novel coronavirus infection.
      • Chen D.
      • Xu W.
      • Lei Z.
      • Huang Z.
      • Liu J.
      • Gao Z.
      • et al.
      Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report.
      • Chen J.
      • Qi T.
      • Liu L.
      • Ling Y.
      • Qian Z.
      • Li T.
      • et al.
      Clinical progression of patients with COVID-19 in Shanghai, China.
      • Chen W.
      • Lan Y.
      • Yuan X.
      • Deng X.
      • Li Y.
      • Cai X.
      • et al.
      Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity.
      • Chen Y.
      • Chen L.
      • Deng Q.
      • Zhang G.
      • Wu K.
      • Ni L.
      • et al.
      The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
      ,
      • Fan Q.
      • Pan Y.
      • Wu Q.
      • Liu S.
      • Song X.
      • Xie Z.
      • et al.
      Anal swab findings in an infant with COVID-19.
      • Fang Z.
      • Zhang Y.
      • Hang C.
      • Zhang W.
      • Ai J.
      • Li S
      Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients.
      • Fu S.
      • Fu X.
      • Song Y.
      • Li M.
      • P-h Pan
      • Tang T.
      • et al.
      Virologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, China.
      ,
      • He X.
      • Lau E.H.
      • Wu P.
      • Deng X.
      • Wang J.
      • Hao X.
      • et al.
      Temporal dynamics in viral shedding and transmissibility of COVID-19.
      ,
      • Hu X.
      • Xing Y.
      • Jia J.
      • Ni W.
      • Liang J.
      • Zhao D.
      • et al.
      Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19.
      ,
      • Hu Z.
      • Song C.
      • Xu C.
      • Jin G.
      • Chen Y.
      • Xu X.
      • et al.
      Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.
      ,
      • Jiang X.
      • Luo M.
      • Zou Z.
      • Wang X.
      • Chen C.
      • Qiu J
      Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days.
      ,
      • Jing Q.-.L.
      • Liu M.-.J.
      • Yuan J.
      • Zhang Z.-.B.
      • Zhang A.-R.
      • Dean N.
      • et al.
      Household secondary attack rate of COVID-19 and associated determinants.
      ,
      • Li N.
      • Wang X.
      • Lv T
      Prolonged SARS-CoV-2 RNA shedding: not a rare phenomenon.
      ,
      • Li Y.
      • Hu Y.
      • Yu Y.
      • Zhang X.
      • Li B.
      • Wu J.
      • et al.
      Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China.
      ,
      • Ling Y.
      • Xu S.-.B.
      • Lin Y.-.X.
      • Tian D.
      • Zhu Z.-.Q.
      • Dai F.-.H.
      • et al.
      Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
      ,
      • Liu F.
      • Xu A.
      • Zhang Y.
      • Xuan W.
      • Yan T.
      • Pan K.
      • et al.
      Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression.
      ,
      • Liu Y.
      • Yan L.-M.
      • Wan L.
      • Xiang T.-.X.
      • Le A.
      • Liu J.-.M.
      • et al.
      Viral dynamics in mild and severe cases of COVID-19.
      • Lo I.L.
      • Lio C.F.
      • Cheong H.H.
      • Lei C.I.
      • Cheong T.H.
      • Zhong X.
      • et al.
      Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau.
      • Lv D-f
      • Ying Q-m
      • Weng Y-s
      • Shen C-b
      • Chu J-g
      • Kong J-p
      • et al.
      Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus disease 2019 patient.
      • Ma X.
      • Su L.
      • Zhang Y.
      • Zhang X.
      • Gai Z.
      • Zhang Z
      Do children need a longer time to shed SARS-CoV-2 in stool than adults?.
      ,
      • Meng J.
      • Xiao G.
      • Zhang J.
      • He X.
      • Ou M.
      • Bi J.
      • et al.
      Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.
      ,
      • Pan Y.
      • Zhang D.
      • Yang P.
      • Poon L.L.M.
      • Wang Q
      Viral load of SARS-CoV-2 in clinical samples.
      ,
      • Peng Z.
      • Wang J.
      • Mo Y.
      • Duan W.
      • Xiang G.
      • Yi M.
      • et al.
      Unlikely SARS-CoV-2 vertical transmission from mother to child: a case report.
      ,
      • Qian G.Q.
      • Chen X.Q.
      • Lv D.F.
      • Ma A.H.Y.
      • Wang L.P.
      • Yang N.B.
      • et al.
      Duration of SARS-CoV-2 viral shedding during COVID-19 infection.
      • Qiu H.
      • Wu J.
      • Hong L.
      • Luo Y.
      • Song Q.
      • Chen D
      Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.
      • Qu Y.-.M.
      • Cong H.-.Y.
      Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19.
      ,
      • Shen C.
      • Wang Z.
      • Zhao F.
      • Yang Y.
      • Li J.
      • Yuan J.
      • et al.
      Treatment of 5 critically ill patients with COVID-19 with convalescent plasma.
      • Shi F.
      • Wu T.
      • Zhu X.
      • Ge Y.
      • Zeng X.
      • Chi Y.
      • et al.
      Association of viral load with serum biomakers among COVID-19 cases.
      • Song R.
      • Han B.
      • Song M.
      • Wang L.
      • Conlon C.P.
      • Dong T.
      • et al.
      Clinical and epidemiological features of COVID-19 family clusters in Beijing, China.
      ,
      • Su L.
      • Ma X.
      • Yu H.
      • Zhang Z.
      • Bian P.
      • Han Y.
      • et al.
      The different clinical characteristics of corona virus disease cases between children and their families in China–the character of children with COVID-19.
      ,
      • Tan L.
      • Kang X.
      • Zhang B.
      • Zheng S.
      • Liu B.
      • Yu T.
      • et al.
      Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: the clinical features, laboratory tests, plasma therapy and implications for public health management.
      ,
      • Tan X.
      • Huang J.
      • Zhao F.
      • Zhou Y.
      • Li J.Q.
      • Wang X.Y
      Clinical features of children with SARS-CoV-2 infection: an analysis of 13 cases from Changsha, China.
      ,
      • Tan Y.P.
      • Tan B.Y.
      • Pan J.
      • Wu J.
      • Zeng S.Z.
      • Wei H.Y
      Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China.
      ,
      • Tu Y.-.H.
      • Wei Y.-.Y.
      • Zhang D.-W.
      • Chen C.-S.
      • Hu X.-.W.
      • Fei G
      Analysis of factors affected the SARS-CoV-2 viral shedding time of COVID-19 patients in Anhui, China: a retrospective study.
      • Wan R.
      • Mao Z.Q.
      • He L.Y.
      • Hu Y.C.
      • Wei C
      Evidence from two cases of asymptomatic infection with SARS-CoV-2: are 14 days of isolation sufficient?.
      • Wang C.
      • Huang L.
      • Lu W.
      • Chen G.
      • Cai Y.
      • Li X.
      • et al.
      Clinical characteristics of pneumonia patients of long courses infected with SARS-CoV-2.
      • Wang J.-.C.
      • Song S.
      • Yuan B.
      • Liu H.-.Q.
      • Yang Z.-.R.
      • Chen Y.-.X.
      • et al.
      Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation.
      • Wang L.
      • Gao Y.H.
      • Lou L.L.
      • Zhang G.J
      The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China.
      • Wang Y.
      • Liu C.
      • Meng Q.
      • Gui S.
      • Wu Y.
      • Cheng P.
      • et al.
      A case report of moderate COVID-19 with an extremely long-term viral shedding period in China.
      ,
      • Wei X.S.
      • Wang X.
      • Niu Y.R.
      • Ye L.L.
      • Peng W.B.
      • Wang Z.H.
      • et al.
      Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19.
      ,
      • Wei X.S.
      • Wang X.R.
      • Zhang J.C.
      • Yang W.B.
      • Ma W.L.
      • Yang B.H.
      • et al.
      A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2.
      ,
      • Wu Y.
      • Guo C.
      • Tang L.
      • Hong Z.
      • Zhou J.
      • Dong X.
      • et al.
      Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.
      • Xiao A.T.
      • Tong Y.X.
      • Gao C.
      • Zhu L.
      • Zhang Y.J.
      • Zhang S
      Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study.
      • Xing Y.
      • Mo P.
      • Xiao Y.
      • Zhao O.
      • Zhang Y.
      • Wang F
      Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020.
      • Xing Y.
      • Ni W.
      • Wu Q.
      • Li W.
      • Li G.
      • Tong J.
      • et al.
      Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019.
      • Xu K.
      • Chen Y.
      • Yuan J.
      • Yi P.
      • Ding C.
      • Wu W.
      • et al.
      Factors associated with prolonged viral RNA shedding in patients with COVID-19.
      • Xu T.
      • Chen C.
      • Zhu Z.
      • Cui M.
      • Chen C.
      • Dai H.
      • et al.
      Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19.
      • Xu T.
      • Huang R.
      • Zhu L.
      • Wang J.
      • Cheng J.
      • Zhang B.
      • et al.
      Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection.
      • Xu Y.
      • Li X.
      • Zhu B.
      • Liang H.
      • Fang C.
      • Gong Y.
      • et al.
      Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.
      • Yan D.
      • Liu X-y
      • Zhu Y-n
      • Huang L.
      • Dan B-t
      • Zhang G-j
      • et al.
      Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in patients with SARS-CoV-2 infection.
      • Yang J.R.
      • Deng D.T.
      • Wu N.
      • Yang B.
      • Li H.J.
      • Pan X.B
      Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.
      • Yang P.
      • Ding Y.
      • Xu Z.
      • Pu R.
      • Li P.
      • Yan J.
      • et al.
      Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China.
      • Yang R.
      • Gui X.
      • Xiong Y
      Patients with respiratory symptoms are at greater risk of COVID-19 transmission.
      • Yongchen Z.
      • Shen H.
      • Wang X.
      • Shi X.
      • Li Y.
      • Yan J.
      • et al.
      Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients.
      ,
      • Yu F.
      • Yan L.
      • Wang N.
      • Yang S.
      • Wang L.
      • Tang Y.
      • et al.
      Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients.
      • Yu X.
      • Sun S.
      • Shi Y.
      • Wang H.
      • Zhao R.
      • Sheng J
      SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression.
      • Yuan J.
      • Kou S.
      • Liang Y.
      • Zeng J.
      • Pan Y.
      • Liu L
      Clinical characteristics on 25 discharged patients with COVID-19 virus returning.
      • Yuan Y.
      • Wang N.
      • Ou X
      Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly.
      • Zha L.
      • Li S.
      • Pan L.
      • Tefsen B.
      • Li Y.
      • French N.
      • et al.
      Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19).
      • Zhang N.
      • Gong Y.
      • Meng F.
      • Bi Y.
      • Yang P.
      • Wang F
      Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients.
      • Zhang T.
      • Cui X.
      • Zhao X.
      • Wang J.
      • Zheng J.
      • Zheng G.
      • et al.
      Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia.
      • Zheng S.
      • Fan J.
      • Yu F.
      • Feng B.
      • Lou B.
      • Zou Q.
      • et al.
      Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
      • Zhou B.
      • She J.
      • Wang Y.
      • Ma X
      The duration of viral shedding of discharged patients with severe COVID-19.
      • Zhou F.
      • Yu T.
      • Du R.
      • Fan G.
      • Liu Y.
      • Liu Z.
      • et al.
      Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
      • Zhu L.
      • Gong N.
      • Liu B.
      • Lu X.
      • Chen D.
      • Chen S.
      • et al.
      Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China.
      • Zou L.
      • Ruan F.
      • Huang M.
      • Liang L.
      • Huang H.
      • Hong Z.
      • et al.
      SARS-CoV-2 viral load in upper respiratory specimens of infected patients.

      Tan L., Kang X., Ji X., Wang Q., li Y., Wang Q., et al. Validation of predictors of disease severity and outcomes in COVID-19 patients: a descriptive and retrospective study. 2020.

      Five studies each were conducted in Taiwan
      • Cheng C.Y.
      • Lee Y.L.
      • Chen C.P.
      • Lin Y.C.
      • Liu C.E.
      • Liao C.H.
      • et al.
      Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
      • Cheng H.-.Y.
      • Jian S.-W.
      • Liu D.-P.
      • Ng T.-C.
      • Huang W.-T.
      • Lin H.-H
      Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset.
      • Cheng S.-.C.
      • Chang Y.-.C.
      • Fan Chiang Y.-.L.
      • Chien Y.-.C.
      • Cheng M.
      • Yang C.-.H.
      • et al.
      First case of Coronavirus disease 2019 (COVID-19) pneumonia in Taiwan.
      ,
      • Lee N.-.Y.
      • Li C.-.W.
      • Tsai H.-.P.
      • Chen P.-.L.
      • Syue L.-S.
      • Li M.-.C.
      • et al.
      A case of COVID-19 and pneumonia returning from Macau in Taiwan: clinical course and anti-SARS-CoV-2 IgG dynamic.
      ,
      • Liu W.D.
      • Chang S.Y.
      • Wang J.T.
      • Tsai M.J.
      • Hung C.C.
      • Hsu C.L.
      • et al.
      Prolonged virus shedding even after seroconversion in a patient with COVID-19.
      and the United States (US).
      • Arons M.M.
      • Hatfield K.M.
      • Reddy S.C.
      • Kimball A.
      • James A.
      • Jacobs J.R.
      • et al.
      Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
      ,
      • Holshue M.L.
      • DeBolt C.
      • Lindquist S.
      • Lofy K.H.
      • Wiesman J.
      • Bruce H.
      • et al.
      First case of 2019 novel coronavirus in the United States.
      ,
      • Kujawski S.A.
      • Wong K.K.
      • Collins J.P.
      • Epstein L.
      • Killerby M.E.
      • Midgley C.M.
      • et al.
      Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.
      ,
      • Scott S.E.
      • Zabel K.
      • Collins J.
      • Hobbs K.C.
      • Kretschmer M.J.
      • Lach M.
      • et al.
      First Mildly Ill, non-hospitalized case of coronavirus disease 2019 (COVID-19) without viral transmission in the United States — Maricopa County, Arizona, 2020.
      ,
      • Segar S.
      • Bouland D.
      • Torriani F.
      • Kwak K.
      • Asudani D.
      • Taplitz R.
      • et al.
      Flight of the COVID-19 patient: experience with aWuhan evacuee- a case report.
      Four studies each were conducted in Singapore
      • Goh K.J.
      • Choong M.C.
      • Cheong E.H.
      • Kalimuddin S.
      • Duu Wen S.
      • Phua G.C.
      • et al.
      Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID-19 infection.
      ,
      • K-q Kam
      • CF Yung
      • Cui L.
      • Lin Tzer Pin R.
      • Mak T.M.
      • Maiwald M.
      • et al.
      A well infant with coronavirus disease 2019 (COVID-19) with high viral load.
      ,
      • Wei W.
      • Li Z.
      • Chiew C.
      • Yong S.
      • Toh M.
      • Lee V
      Presymptomatic transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020.
      ,
      • Young B.E.
      • Ong S.W.X.
      • Kalimuddin S.
      • Low J.G.
      • Tan S.Y.
      • Loh J.
      • et al.
      Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore.
      and Italy,
      • Lavezzo E.
      • Franchin E.
      • Ciavarella C.
      • Cuomo-Dannenburg G.
      • Barzon L.
      • Del Vecchio C.
      • et al.
      Suppression of COVID-19 outbreak in the municipality of Vo, Italy.
      ,
      • Nicastri E.
      • D'Abramo A.
      • Faggioni G.
      • De Santis R.
      • Mariano A.
      • Lepore L.
      • et al.
      Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020.
      ,
      • Paoli D.
      • Pallotti F.
      • Colangelo S.
      • Basilico F.
      • Mazzuti L.
      • Turriziani O.
      • et al.
      Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab.
      ,
      • Stebbing J.
      • Krishnan V.
      • Sd Bono
      • Ottaviani S.
      • Casalini G.
      • Richardson P.
      • et al.
      Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
      three studies each were conducted in Germany,
      • Corman V.M.
      • Rabenau H.F.
      • Adams O.
      • Oberle D.
      • Funk M.B.
      • Keller-Stanislawski B.
      • et al.
      SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.
      ,

      Jones T.C., Mühlemann B., Veith T., Zuchowski M., Hofmann J., Stein A., et al. An analysis of SARS-CoV-2 viral load by patient age. https://zoonosen.charite.de/fileadmin/user_upload/microsites/m_cc05/virologie-ccm/dateien_upload/Weitere_Dateien/analysis-of-SARS-CoV-2-viral-load-by-patient-age.pdf: 2020.

      ,
      • Woelfel R.
      • Corman V.M.
      • Guggemos W.
      • Seilmaier M.
      • Zange S.
      • Mueller M.A.
      • et al.
      Virological assessment of hospitalized patients With COVID-2019.
      France
      • Gautret P.
      • Lagier J.C.
      • Parola P.
      • Hoang V.T.
      • Meddeb L.
      • Mailhe M.
      • et al.
      Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
      ,
      • La Scola B.
      • Le Bideau M.
      • Andreani J.
      • Hoang V.T.
      • Grimaldier C.
      • Colson P.
      • et al.
      Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.
      ,
      • Lescure F.-.X.
      • Bouadma L.
      • Nguyen D.
      • Parisey M.
      • Wicky P.-H.
      • Behillil S.
      • et al.
      Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
      and Vietnam,
      • Le H.T.
      • Nguyen L.V.
      • Tran D.M.
      • Do H.T.
      • Tran H.T.
      • Le Y.T.
      • et al.
      The first infant case of COVID-19 acquired from a secondary transmission in Vietnam.
      ,
      • Le T.Q.M.
      • Takemura T.
      • Moi M.L.
      • Nabeshima T.
      • Nguyen L.K.H.
      • Hoang V.M.P.
      • et al.
      Severe acute respiratory syndrome coronavirus 2 shedding by travelers, Vietnam, 2020.
      ,
      • Tan L.V.
      • Ngoc N.M.
      • That B.T.T.
      • Uyen L.T.T.
      • Hong N.T.T.
      • Dung N.T.P.
      • et al.
      Duration of viral detection in throat and rectum of a patient with COVID-19.
      two studies each were conducted in Hong Kong,
      • To K.K.-.W.
      • Tsang O.T.-.Y.
      • Leung W.-.S.
      • Tam A.R.
      • Wu T.-.C.
      • Lung D.C.
      • et al.
      Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
      ,
      • To K.K.-.W.
      • Tsang O.T.-.Y.
      • Yip C.C.-.Y.
      • Chan K.-.H.
      • Wu T.-.C.
      • Chan J.M.-.C.
      • et al.
      Consistent detection of 2019 novel coronavirus in Saliva.
      the United Kingdom (UK)
      • Hill D.K.J.
      • Russell D.C.D.
      • Clifford D.S.
      • Templeton D.K.
      • Mackintosh D.C.L.
      • Koch D.O.
      • et al.
      The index case of SARS-CoV-2 in Scotland: a case report.
      ,
      • Lillie P.J.
      • Samson A.
      • Li A.
      • Adams K.
      • Capstick R.
      • Barlow G.D.
      • et al.
      Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission.
      and South Korea,
      • Kim J.Y.
      • Ko J.H.
      • Kim Y.
      • Kim Y.J.
      • Kim J.M.
      • Chung Y.S.
      • et al.
      Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.
      ,
      • Lim J.
      • Jeon S.
      • Shin H.Y.
      • Kim M.J.
      • Seong Y.M.
      • Lee W.J.
      • et al.
      Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR.
      with one study conducted in each of the following: Bangladesh,
      • Jahan Y.
      • Rahman S.
      • Rahman A
      COVID-19: a case report from Bangladesh perspective.
      Switzerland,
      • L'Huillier A.
      • Torriani G.
      • Pigny F.
      • Kaiser L.
      • Eckerle I
      Shedding of infectious SARS-CoV-2 in symptomatic neonates, children and adolescents.
      Thailand,
      • Pongpirul W.A.
      • Mott J.A.
      • Woodring J.V.
      • Uyeki T.M.
      • MacArthur J.R.
      • Vachiraphan A.
      • et al.
      Clinical characteristics of patients hospitalized with coronavirus disease, Thailand.
      Japan,
      • Saito M.
      • Adachi E.
      • Yamayoshi S.
      • Koga M.
      • Iwatsuki-Horimoto K.
      • Kawaoka Y.
      • et al.
      Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan.
      Australia,
      • Thevarajan I.
      • Nguyen T.H.O.
      • Koutsakos M.
      • Druce J.
      • Caly L.
      • van de Sandt C.E.
      • et al.
      Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19.
      and Canada.
      • Marchand-Senécal X.
      • Kozak R.
      • Mubareka S.
      • Salt N.
      • Gubbay J.B.
      • Eshaghi A.
      • et al.
      Diagnosis and management of first case of COVID-19 in Canada: lessons applied from SARS.
      One hundred-and-eleven studies were observational in nature,
      • An J.
      • Liao X.
      • Xiao T.
      • Qian S.
      • Yuan J.
      • Ye H.
      • et al.
      Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test.
      • Arons M.M.
      • Hatfield K.M.
      • Reddy S.C.
      • Kimball A.
      • James A.
      • Jacobs J.R.
      • et al.
      Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
      • Cai J.
      • Xu J.
      • Lin D.
      • z Yang
      • Xu L.
      • Qu Z.
      • et al.
      A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features.
      • Cai Q.
      • Huang D.
      • Ou P.
      • Yu H.
      • Zhu Z.
      • Xia Z.
      • et al.
      COVID-19 in a designated infectious diseases hospital outside Hubei Province,China.
      ,
      • Chang Mo G
      • Yuan X.
      • Tao Y.
      • Peng X.
      • Wang F.
      • et al.
      Time kinetics of viral clearance and resolution of symptoms in novel coronavirus infection.
      • Chen D.
      • Xu W.
      • Lei Z.
      • Huang Z.
      • Liu J.
      • Gao Z.
      • et al.
      Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report.
      • Chen J.
      • Qi T.
      • Liu L.
      • Ling Y.
      • Qian Z.
      • Li T.
      • et al.
      Clinical progression of patients with COVID-19 in Shanghai, China.
      • Chen W.
      • Lan Y.
      • Yuan X.
      • Deng X.
      • Li Y.
      • Cai X.
      • et al.
      Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity.
      • Chen Y.
      • Chen L.
      • Deng Q.
      • Zhang G.
      • Wu K.
      • Ni L.
      • et al.
      The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
      • Cheng C.Y.
      • Lee Y.L.
      • Chen C.P.
      • Lin Y.C.
      • Liu C.E.
      • Liao C.H.
      • et al.
      Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
      • Cheng H.-.Y.
      • Jian S.-W.
      • Liu D.-P.
      • Ng T.-C.
      • Huang W.-T.
      • Lin H.-H
      Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset.
      • Cheng S.-.C.
      • Chang Y.-.C.
      • Fan Chiang Y.-.L.
      • Chien Y.-.C.
      • Cheng M.
      • Yang C.-.H.
      • et al.
      First case of Coronavirus disease 2019 (COVID-19) pneumonia in Taiwan.
      • Corman V.M.
      • Rabenau H.F.
      • Adams O.
      • Oberle D.
      • Funk M.B.
      • Keller-Stanislawski B.
      • et al.
      SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.
      • Fan Q.
      • Pan Y.
      • Wu Q.
      • Liu S.
      • Song X.
      • Xie Z.
      • et al.
      Anal swab findings in an infant with COVID-19.
      • Fang Z.
      • Zhang Y.
      • Hang C.
      • Zhang W.
      • Ai J.
      • Li S
      Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients.
      • Fu S.
      • Fu X.
      • Song Y.
      • Li M.
      • P-h Pan
      • Tang T.
      • et al.
      Virologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, China.
      • Gao J.
      • Liu J.Q.
      • Wen H.J.
      • Liu H.
      • Hu W.D.
      • Han X.
      • et al.
      The unsynchronized changes of CT image and nucleic acid detection in COVID-19: reports the two cases from Gansu, China.
      ,
      • Goh K.J.
      • Choong M.C.
      • Cheong E.H.
      • Kalimuddin S.
      • Duu Wen S.
      • Phua G.C.
      • et al.
      Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID-19 infection.
      • He X.
      • Lau E.H.
      • Wu P.
      • Deng X.
      • Wang J.
      • Hao X.
      • et al.
      Temporal dynamics in viral shedding and transmissibility of COVID-19.
      • Hill D.K.J.
      • Russell D.C.D.
      • Clifford D.S.
      • Templeton D.K.
      • Mackintosh D.C.L.
      • Koch D.O.
      • et al.
      The index case of SARS-CoV-2 in Scotland: a case report.
      • Holshue M.L.
      • DeBolt C.
      • Lindquist S.
      • Lofy K.H.
      • Wiesman J.
      • Bruce H.
      • et al.
      First case of 2019 novel coronavirus in the United States.
      • Hu X.
      • Xing Y.
      • Jia J.
      • Ni W.
      • Liang J.
      • Zhao D.
      • et al.
      Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19.
      • Hu Z.
      • Song C.
      • Xu C.
      • Jin G.
      • Chen Y.
      • Xu X.
      • et al.
      Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.
      • Huang J.
      • Mao T.
      • Li S.
      • Wu L.
      • Xu X.
      • Li H.
      • et al.
      Long period dynamics of viral load and antibodies for SARS-CoV-2 infection: an observational cohort study.
      • Jahan Y.
      • Rahman S.
      • Rahman A
      COVID-19: a case report from Bangladesh perspective.
      • Jiang X.
      • Luo M.
      • Zou Z.
      • Wang X.
      • Chen C.
      • Qiu J
      Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days.
      • Jing Q.-.L.
      • Liu M.-.J.
      • Yuan J.
      • Zhang Z.-.B.
      • Zhang A.-R.
      • Dean N.
      • et al.
      Household secondary attack rate of COVID-19 and associated determinants.

      Jones T.C., Mühlemann B., Veith T., Zuchowski M., Hofmann J., Stein A., et al. An analysis of SARS-CoV-2 viral load by patient age. https://zoonosen.charite.de/fileadmin/user_upload/microsites/m_cc05/virologie-ccm/dateien_upload/Weitere_Dateien/analysis-of-SARS-CoV-2-viral-load-by-patient-age.pdf: 2020.

      • K-q Kam
      • CF Yung
      • Cui L.
      • Lin Tzer Pin R.
      • Mak T.M.
      • Maiwald M.
      • et al.
      A well infant with coronavirus disease 2019 (COVID-19) with high viral load.
      • Kim J.Y.
      • Ko J.H.
      • Kim Y.
      • Kim Y.J.
      • Kim J.M.
      • Chung Y.S.
      • et al.
      Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.
      • Kujawski S.A.
      • Wong K.K.
      • Collins J.P.
      • Epstein L.
      • Killerby M.E.
      • Midgley C.M.
      • et al.
      Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.
      • La Scola B.
      • Le Bideau M.
      • Andreani J.
      • Hoang V.T.
      • Grimaldier C.
      • Colson P.
      • et al.
      Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.
      • Lavezzo E.
      • Franchin E.
      • Ciavarella C.
      • Cuomo-Dannenburg G.
      • Barzon L.
      • Del Vecchio C.
      • et al.
      Suppression of COVID-19 outbreak in the municipality of Vo, Italy.
      • Le H.T.
      • Nguyen L.V.
      • Tran D.M.
      • Do H.T.
      • Tran H.T.
      • Le Y.T.
      • et al.
      The first infant case of COVID-19 acquired from a secondary transmission in Vietnam.
      • Le T.Q.M.
      • Takemura T.
      • Moi M.L.
      • Nabeshima T.
      • Nguyen L.K.H.
      • Hoang V.M.P.
      • et al.
      Severe acute respiratory syndrome coronavirus 2 shedding by travelers, Vietnam, 2020.
      • Lee N.-.Y.
      • Li C.-.W.
      • Tsai H.-.P.
      • Chen P.-.L.
      • Syue L.-S.
      • Li M.-.C.
      • et al.
      A case of COVID-19 and pneumonia returning from Macau in Taiwan: clinical course and anti-SARS-CoV-2 IgG dynamic.
      • Lescure F.-.X.
      • Bouadma L.
      • Nguyen D.
      • Parisey M.
      • Wicky P.-H.
      • Behillil S.
      • et al.
      Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
      • L'Huillier A.
      • Torriani G.
      • Pigny F.
      • Kaiser L.
      • Eckerle I
      Shedding of infectious SARS-CoV-2 in symptomatic neonates, children and adolescents.
      • Li N.
      • Wang X.
      • Lv T
      Prolonged SARS-CoV-2 RNA shedding: not a rare phenomenon.
      • Li Y.
      • Hu Y.
      • Yu Y.
      • Zhang X.
      • Li B.
      • Wu J.
      • et al.
      Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China.
      • Lillie P.J.
      • Samson A.
      • Li A.
      • Adams K.
      • Capstick R.
      • Barlow G.D.
      • et al.
      Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission.
      • Lim J.
      • Jeon S.
      • Shin H.Y.
      • Kim M.J.
      • Seong Y.M.
      • Lee W.J.
      • et al.
      Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR.
      • Ling Y.
      • Xu S.-.B.
      • Lin Y.-.X.
      • Tian D.
      • Zhu Z.-.Q.
      • Dai F.-.H.
      • et al.
      Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
      • Liu F.
      • Xu A.
      • Zhang Y.
      • Xuan W.
      • Yan T.
      • Pan K.
      • et al.
      Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression.
      • Liu W.D.
      • Chang S.Y.
      • Wang J.T.
      • Tsai M.J.
      • Hung C.C.
      • Hsu C.L.
      • et al.
      Prolonged virus shedding even after seroconversion in a patient with COVID-19.
      • Liu Y.
      • Yan L.-M.
      • Wan L.
      • Xiang T.-.X.
      • Le A.
      • Liu J.-.M.
      • et al.
      Viral dynamics in mild and severe cases of COVID-19.
      • Lo I.L.
      • Lio C.F.
      • Cheong H.H.
      • Lei C.I.
      • Cheong T.H.
      • Zhong X.
      • et al.
      Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau.
      • Lv D-f
      • Ying Q-m
      • Weng Y-s
      • Shen C-b
      • Chu J-g
      • Kong J-p
      • et al.
      Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus disease 2019 patient.
      • Ma X.
      • Su L.
      • Zhang Y.
      • Zhang X.
      • Gai Z.
      • Zhang Z
      Do children need a longer time to shed SARS-CoV-2 in stool than adults?.
      • Marchand-Senécal X.
      • Kozak R.
      • Mubareka S.
      • Salt N.
      • Gubbay J.B.
      • Eshaghi A.
      • et al.
      Diagnosis and management of first case of COVID-19 in Canada: lessons applied from SARS.
      • Meng J.
      • Xiao G.
      • Zhang J.
      • He X.
      • Ou M.
      • Bi J.
      • et al.
      Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.
      • Nicastri E.
      • D'Abramo A.
      • Faggioni G.
      • De Santis R.
      • Mariano A.
      • Lepore L.
      • et al.
      Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020.
      • Pan Y.
      • Zhang D.
      • Yang P.
      • Poon L.L.M.
      • Wang Q
      Viral load of SARS-CoV-2 in clinical samples.
      • Paoli D.
      • Pallotti F.
      • Colangelo S.
      • Basilico F.
      • Mazzuti L.
      • Turriziani O.
      • et al.
      Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab.
      • Peng Z.
      • Wang J.
      • Mo Y.
      • Duan W.
      • Xiang G.
      • Yi M.
      • et al.
      Unlikely SARS-CoV-2 vertical transmission from mother to child: a case report.
      • Pongpirul W.A.
      • Mott J.A.
      • Woodring J.V.
      • Uyeki T.M.
      • MacArthur J.R.
      • Vachiraphan A.
      • et al.
      Clinical characteristics of patients hospitalized with coronavirus disease, Thailand.
      • Qian G.Q.
      • Chen X.Q.
      • Lv D.F.
      • Ma A.H.Y.
      • Wang L.P.
      • Yang N.B.
      • et al.
      Duration of SARS-CoV-2 viral shedding during COVID-19 infection.
      • Qiu H.
      • Wu J.
      • Hong L.
      • Luo Y.
      • Song Q.
      • Chen D
      Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.
      • Qu Y.-.M.
      • Cong H.-.Y.
      Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19.
      • Saito M.
      • Adachi E.
      • Yamayoshi S.
      • Koga M.
      • Iwatsuki-Horimoto K.
      • Kawaoka Y.
      • et al.
      Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan.
      • Scott S.E.
      • Zabel K.
      • Collins J.
      • Hobbs K.C.
      • Kretschmer M.J.
      • Lach M.
      • et al.
      First Mildly Ill, non-hospitalized case of coronavirus disease 2019 (COVID-19) without viral transmission in the United States — Maricopa County, Arizona, 2020.
      • Segar S.
      • Bouland D.
      • Torriani F.
      • Kwak K.
      • Asudani D.
      • Taplitz R.
      • et al.
      Flight of the COVID-19 patient: experience with aWuhan evacuee- a case report.
      • Shen C.
      • Wang Z.
      • Zhao F.
      • Yang Y.
      • Li J.
      • Yuan J.
      • et al.
      Treatment of 5 critically ill patients with COVID-19 with convalescent plasma.
      • Shi F.
      • Wu T.
      • Zhu X.
      • Ge Y.
      • Zeng X.
      • Chi Y.
      • et al.
      Association of viral load with serum biomakers among COVID-19 cases.
      • Song R.
      • Han B.
      • Song M.
      • Wang L.
      • Conlon C.P.
      • Dong T.
      • et al.
      Clinical and epidemiological features of COVID-19 family clusters in Beijing, China.
      • Stebbing J.
      • Krishnan V.
      • Sd Bono
      • Ottaviani S.
      • Casalini G.
      • Richardson P.
      • et al.
      Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
      • Su L.
      • Ma X.
      • Yu H.
      • Zhang Z.
      • Bian P.
      • Han Y.
      • et al.
      The different clinical characteristics of corona virus disease cases between children and their families in China–the character of children with COVID-19.
      ,
      • Tan L.
      • Kang X.
      • Zhang B.
      • Zheng S.
      • Liu B.
      • Yu T.
      • et al.
      Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days: the clinical features, laboratory tests, plasma therapy and implications for public health management.
      • Tan L.V.
      • Ngoc N.M.
      • That B.T.T.
      • Uyen L.T.T.
      • Hong N.T.T.
      • Dung N.T.P.
      • et al.
      Duration of viral detection in throat and rectum of a patient with COVID-19.
      • Tan X.
      • Huang J.
      • Zhao F.
      • Zhou Y.
      • Li J.Q.
      • Wang X.Y
      Clinical features of children with SARS-CoV-2 infection: an analysis of 13 cases from Changsha, China.
      • Tan Y.P.
      • Tan B.Y.
      • Pan J.
      • Wu J.
      • Zeng S.Z.
      • Wei H.Y
      Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China.
      • Thevarajan I.
      • Nguyen T.H.O.
      • Koutsakos M.
      • Druce J.
      • Caly L.
      • van de Sandt C.E.
      • et al.
      Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19.
      • To K.K.-.W.
      • Tsang O.T.-.Y.
      • Leung W.-.S.
      • Tam A.R.
      • Wu T.-.C.
      • Lung D.C.
      • et al.
      Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
      • To K.K.-.W.
      • Tsang O.T.-.Y.
      • Yip C.C.-.Y.
      • Chan K.-.H.
      • Wu T.-.C.
      • Chan J.M.-.C.
      • et al.
      Consistent detection of 2019 novel coronavirus in Saliva.
      • Tu Y.-.H.
      • Wei Y.-.Y.
      • Zhang D.-W.
      • Chen C.-S.
      • Hu X.-.W.
      • Fei G
      Analysis of factors affected the SARS-CoV-2 viral shedding time of COVID-19 patients in Anhui, China: a retrospective study.
      • Wan R.
      • Mao Z.Q.
      • He L.Y.
      • Hu Y.C.
      • Wei C
      Evidence from two cases of asymptomatic infection with SARS-CoV-2: are 14 days of isolation sufficient?.
      • Wang C.
      • Huang L.
      • Lu W.
      • Chen G.
      • Cai Y.
      • Li X.
      • et al.
      Clinical characteristics of pneumonia patients of long courses infected with SARS-CoV-2.
      • Wang J.-.C.
      • Song S.
      • Yuan B.
      • Liu H.-.Q.
      • Yang Z.-.R.
      • Chen Y.-.X.
      • et al.
      Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation.
      • Wang L.
      • Gao Y.H.
      • Lou L.L.
      • Zhang G.J
      The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China.
      • Wang Y.
      • Liu C.
      • Meng Q.
      • Gui S.
      • Wu Y.
      • Cheng P.
      • et al.
      A case report of moderate COVID-19 with an extremely long-term viral shedding period in China.
      • Wei W.
      • Li Z.
      • Chiew C.
      • Yong S.
      • Toh M.
      • Lee V
      Presymptomatic transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020.
      • Wei X.S.
      • Wang X.
      • Niu Y.R.
      • Ye L.L.
      • Peng W.B.
      • Wang Z.H.
      • et al.
      Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19.
      • Wei X.S.
      • Wang X.R.
      • Zhang J.C.
      • Yang W.B.
      • Ma W.L.
      • Yang B.H.
      • et al.
      A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2.
      • Woelfel R.
      • Corman V.M.
      • Guggemos W.
      • Seilmaier M.
      • Zange S.
      • Mueller M.A.
      • et al.
      Virological assessment of hospitalized patients With COVID-2019.
      • Wu Y.
      • Guo C.
      • Tang L.
      • Hong Z.
      • Zhou J.
      • Dong X.
      • et al.
      Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.
      • Xiao A.T.
      • Tong Y.X.
      • Gao C.
      • Zhu L.
      • Zhang Y.J.
      • Zhang S
      Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study.
      • Xing Y.
      • Mo P.
      • Xiao Y.
      • Zhao O.
      • Zhang Y.
      • Wang F
      Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020.
      • Xing Y.
      • Ni W.
      • Wu Q.
      • Li W.
      • Li G.
      • Tong J.
      • et al.
      Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019.
      • Xu K.
      • Chen Y.
      • Yuan J.
      • Yi P.
      • Ding C.
      • Wu W.
      • et al.
      Factors associated with prolonged viral RNA shedding in patients with COVID-19.
      • Xu T.
      • Chen C.
      • Zhu Z.
      • Cui M.
      • Chen C.
      • Dai H.
      • et al.
      Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19.
      • Xu T.
      • Huang R.
      • Zhu L.
      • Wang J.
      • Cheng J.
      • Zhang B.
      • et al.
      Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection.
      • Xu Y.
      • Li X.
      • Zhu B.
      • Liang H.
      • Fang C.
      • Gong Y.
      • et al.
      Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.
      • Yan D.
      • Liu X-y
      • Zhu Y-n
      • Huang L.
      • Dan B-t
      • Zhang G-j
      • et al.
      Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in patients with SARS-CoV-2 infection.
      • Yang J.R.
      • Deng D.T.
      • Wu N.
      • Yang B.
      • Li H.J.
      • Pan X.B
      Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.
      • Yang P.
      • Ding Y.
      • Xu Z.
      • Pu R.
      • Li P.
      • Yan J.
      • et al.
      Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China.
      • Yang R.
      • Gui X.
      • Xiong Y
      Patients with respiratory symptoms are at greater risk of COVID-19 transmission.
      • Yongchen Z.
      • Shen H.
      • Wang X.
      • Shi X.
      • Li Y.
      • Yan J.
      • et al.
      Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients.
      • Young B.E.
      • Ong S.W.X.
      • Kalimuddin S.
      • Low J.G.
      • Tan S.Y.
      • Loh J.
      • et al.
      Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore.
      • Yu F.
      • Yan L.
      • Wang N.
      • Yang S.
      • Wang L.
      • Tang Y.
      • et al.
      Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients.
      • Yu X.
      • Sun S.
      • Shi Y.
      • Wang H.
      • Zhao R.
      • Sheng J
      SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression.
      • Yuan J.
      • Kou S.
      • Liang Y.
      • Zeng J.
      • Pan Y.
      • Liu L
      Clinical characteristics on 25 discharged patients with COVID-19 virus returning.
      • Yuan Y.
      • Wang N.
      • Ou X
      Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly.
      • Zha L.
      • Li S.
      • Pan L.
      • Tefsen B.
      • Li Y.
      • French N.
      • et al.
      Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19).
      • Zhang N.
      • Gong Y.
      • Meng F.
      • Bi Y.
      • Yang P.
      • Wang F
      Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients.
      • Zhang T.
      • Cui X.
      • Zhao X.
      • Wang J.
      • Zheng J.
      • Zheng G.
      • et al.
      Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia.
      • Zheng S.
      • Fan J.
      • Yu F.
      • Feng B.
      • Lou B.
      • Zou Q.
      • et al.
      Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
      • Zhou B.
      • She J.
      • Wang Y.
      • Ma X
      The duration of viral shedding of discharged patients with severe COVID-19.
      • Zhou F.
      • Yu T.
      • Du R.
      • Fan G.
      • Liu Y.
      • Liu Z.
      • et al.
      Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
      • Zhu L.
      • Gong N.
      • Liu B.
      • Lu X.
      • Chen D.
      • Chen S.
      • et al.
      Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China.
      • Zou L.
      • Ruan F.
      • Huang M.
      • Liang L.
      • Huang H.
      • Hong Z.
      • et al.
      SARS-CoV-2 viral load in upper respiratory specimens of infected patients.

      Tan L., Kang X., Ji X., Wang Q., li Y., Wang Q., et al. Validation of predictors of disease severity and outcomes in COVID-19 patients: a descriptive and retrospective study. 2020.

      one study was a randomised controlled trial (RCT)
      • Cao B.
      • Wang Y.
      • Wen D.
      • Liu W.
      • Wang J.
      • Fan G.
      • et al.
      A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19.
      and one was a non-randomised controlled trial (NRCT).
      • Gautret P.
      • Lagier J.C.
      • Parola P.
      • Hoang V.T.
      • Meddeb L.
      • Mailhe M.
      • et al.
      Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
      The majority of included observational studies (n = 95) were case reports or series.
      • An J.
      • Liao X.
      • Xiao T.
      • Qian S.
      • Yuan J.
      • Ye H.
      • et al.
      Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test.
      ,
      • Cai J.
      • Xu J.
      • Lin D.
      • z Yang
      • Xu L.
      • Qu Z.
      • et al.
      A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features.
      ,
      • Cai Q.
      • Huang D.
      • Ou P.
      • Yu H.
      • Zhu Z.
      • Xia Z.
      • et al.
      COVID-19 in a designated infectious diseases hospital outside Hubei Province,China.
      ,
      • Chang Mo G
      • Yuan X.
      • Tao Y.
      • Peng X.
      • Wang F.
      • et al.
      Time kinetics of viral clearance and resolution of symptoms in novel coronavirus infection.
      • Chen D.
      • Xu W.
      • Lei Z.
      • Huang Z.
      • Liu J.
      • Gao Z.
      • et al.
      Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report.
      • Chen J.
      • Qi T.
      • Liu L.
      • Ling Y.
      • Qian Z.
      • Li T.
      • et al.
      Clinical progression of patients with COVID-19 in Shanghai, China.
      • Chen W.
      • Lan Y.
      • Yuan X.
      • Deng X.
      • Li Y.
      • Cai X.
      • et al.
      Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity.
      • Chen Y.
      • Chen L.
      • Deng Q.
      • Zhang G.
      • Wu K.
      • Ni L.
      • et al.
      The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
      • Cheng C.Y.
      • Lee Y.L.
      • Chen C.P.
      • Lin Y.C.
      • Liu C.E.
      • Liao C.H.
      • et al.
      Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
      ,
      • Cheng S.-.C.
      • Chang Y.-.C.
      • Fan Chiang Y.-.L.
      • Chien Y.-.C.
      • Cheng M.
      • Yang C.-.H.
      • et al.
      First case of Coronavirus disease 2019 (COVID-19) pneumonia in Taiwan.
      • Corman V.M.
      • Rabenau H.F.
      • Adams O.
      • Oberle D.
      • Funk M.B.
      • Keller-Stanislawski B.
      • et al.
      SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.
      • Fan Q.
      • Pan Y.
      • Wu Q.
      • Liu S.
      • Song X.
      • Xie Z.
      • et al.
      Anal swab findings in an infant with COVID-19.
      • Fang Z.
      • Zhang Y.
      • Hang C.
      • Zhang W.
      • Ai J.
      • Li S
      Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients.
      • Fu S.
      • Fu X.
      • Song Y.
      • Li M.
      • P-h Pan
      • Tang T.
      • et al.
      Virologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, China.
      • Gao J.
      • Liu J.Q.
      • Wen H.J.
      • Liu H.
      • Hu W.D.
      • Han X.
      • et al.
      The unsynchronized changes of CT image and nucleic acid detection in COVID-19: reports the two cases from Gansu, China.
      ,
      • Goh K.J.
      • Choong M.C.
      • Cheong E.H.
      • Kalimuddin S.
      • Duu Wen S.
      • Phua G.C.
      • et al.
      Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID-19 infection.
      ,
      • Hill D.K.J.
      • Russell D.C.D.
      • Clifford D.S.
      • Templeton D.K.
      • Mackintosh D.C.L.
      • Koch D.O.
      • et al.
      The index case of SARS-CoV-2 in Scotland: a case report.
      ,
      • Holshue M.L.
      • DeBolt C.
      • Lindquist S.
      • Lofy K.H.
      • Wiesman J.
      • Bruce H.
      • et al.
      First case of 2019 novel coronavirus in the United States.
      ,
      • Hu Z.
      • Song C.
      • Xu C.
      • Jin G.
      • Chen Y.
      • Xu X.
      • et al.
      Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.
      • Huang J.
      • Mao T.
      • Li S.
      • Wu L.
      • Xu X.
      • Li H.
      • et al.
      Long period dynamics of viral load and antibodies for SARS-CoV-2 infection: an observational cohort study.
      • Jahan Y.
      • Rahman S.
      • Rahman A
      COVID-19: a case report from Bangladesh perspective.
      • Jiang X.
      • Luo M.
      • Zou Z.
      • Wang X.
      • Chen C.
      • Qiu J
      Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days.
      ,
      • K-q Kam
      • CF Yung
      • Cui L.
      • Lin Tzer Pin R.
      • Mak T.M.
      • Maiwald M.
      • et al.
      A well infant with coronavirus disease 2019 (COVID-19) with high viral load.
      • Kim J.Y.
      • Ko J.H.
      • Kim Y.
      • Kim Y.J.
      • Kim J.M.
      • Chung Y.S.
      • et al.
      Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.
      • Kujawski S.A.
      • Wong K.K.
      • Collins J.P.
      • Epstein L.
      • Killerby M.E.
      • Midgley C.M.
      • et al.
      Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States.
      ,
      • Le H.T.
      • Nguyen L.V.
      • Tran D.M.
      • Do H.T.
      • Tran H.T.
      • Le Y.T.
      • et al.
      The first infant case of COVID-19 acquired from a secondary transmission in Vietnam.
      • Le T.Q.M.
      • Takemura T.
      • Moi M.L.
      • Nabeshima T.
      • Nguyen L.K.H.
      • Hoang V.M.P.
      • et al.
      Severe acute respiratory syndrome coronavirus 2 shedding by travelers, Vietnam, 2020.
      • Lee N.-.Y.
      • Li C.-.W.
      • Tsai H.-.P.
      • Chen P.-.L.
      • Syue L.-S.
      • Li M.-.C.
      • et al.
      A case of COVID-19 and pneumonia returning from Macau in Taiwan: clinical course and anti-SARS-CoV-2 IgG dynamic.
      • Lescure F.-.X.
      • Bouadma L.
      • Nguyen D.
      • Parisey M.
      • Wicky P.-H.
      • Behillil S.
      • et al.
      Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
      • L'Huillier A.
      • Torriani G.
      • Pigny F.
      • Kaiser L.
      • Eckerle I
      Shedding of infectious SARS-CoV-2 in symptomatic neonates, children and adolescents.
      • Li N.
      • Wang X.
      • Lv T
      Prolonged SARS-CoV-2 RNA shedding: not a rare phenomenon.
      • Li Y.
      • Hu Y.
      • Yu Y.
      • Zhang X.
      • Li B.
      • Wu J.
      • et al.
      Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China.
      • Lillie P.J.
      • Samson A.
      • Li A.
      • Adams K.
      • Capstick R.
      • Barlow G.D.
      • et al.
      Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission.
      • Lim J.
      • Jeon S.
      • Shin H.Y.
      • Kim M.J.
      • Seong Y.M.
      • Lee W.J.
      • et al.
      Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR.
      • Ling Y.
      • Xu S.-.B.
      • Lin Y.-.X.
      • Tian D.
      • Zhu Z.-.Q.
      • Dai F.-.H.
      • et al.
      Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
      • Liu F.
      • Xu A.
      • Zhang Y.
      • Xuan W.
      • Yan T.
      • Pan K.
      • et al.
      Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression.
      • Liu W.D.
      • Chang S.Y.
      • Wang J.T.
      • Tsai M.J.
      • Hung C.C.
      • Hsu C.L.
      • et al.
      Prolonged virus shedding even after seroconversion in a patient with COVID-19.
      • Liu Y.
      • Yan L.-M.
      • Wan L.
      • Xiang T.-.X.
      • Le A.
      • Liu J.-.M.
      • et al.
      Viral dynamics in mild and severe cases of COVID-19.